Comments

CalciMedica

CALCNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$3.94
0.061.55%
At Close: -
$4.86
0.9223.35%
After Hours: Jul 17, 9:25 AM EDT
15 minutes delayed
CalciMedica (CALC) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$17.00
Consensus Price Target1
$19.80

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

CalciMedica (NASDAQ:CALC) Stock, Analyst Ratings, Price Targets, Forecasts

CalciMedica Inc has a consensus price target of $19.8 based on the ratings of 5 analysts. The high is $22 issued by JonesTrading on February 16, 2024. The low is $17 issued by EF Hutton on July 7, 2023. The 3 most-recent analyst ratings were released by Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co. on July 10, 2024, July 9, 2024, and June 27, 2024, respectively. With an average price target of $20 between Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 311.52% upside for CalciMedica Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
0
0
0
0
May
0
0
0
0
Jun
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
HC Wainwright & Co.
HC Wainwright & Co.
JonesTrading
EF Hutton

1calculated from analyst ratings

Analyst Ratings for CalciMedica

Buy NowGet Alert
07/10/2024Buy Now311.52%Oppenheimer
Leland Gershell
$14 → $20MaintainsOutperformGet Alert
07/09/2024Buy Now311.52%HC Wainwright & Co.
Joseph Pantginis
$20 → $20ReiteratesBuy → BuyGet Alert
06/27/2024Buy Now311.52%HC Wainwright & Co.
Joseph Pantginis
$20 → $20ReiteratesBuy → BuyGet Alert
05/14/2024Buy Now311.52%HC Wainwright & Co.
Joseph Pantginis
 → $20ReiteratesBuy → BuyGet Alert
04/01/2024Buy Now311.52%HC Wainwright & Co.
Swayampakula Ramakanth
 → $20ReiteratesBuy → BuyGet Alert
04/01/2024Buy Now188.07%Oppenheimer
Leland Gershell
$14 → $14MaintainsOutperformGet Alert
03/13/2024Buy Now311.52%HC Wainwright & Co.
Joseph Pantginis
 → $20ReiteratesBuy → BuyGet Alert
02/16/2024Buy Now352.67%JonesTrading
Catherine Novack
 → $22Initiates → BuyGet Alert
02/13/2024Buy Now311.52%HC Wainwright & Co.
Joseph Pantginis
 → $20ReiteratesBuy → BuyGet Alert
01/29/2024Buy Now311.52%HC Wainwright & Co.
Joseph Pantginis
 → $20Initiates → BuyGet Alert
11/13/2023Buy Now188.07%Oppenheimer
Leland Gershell
 → $14ReiteratesOutperform → OutperformGet Alert
07/07/2023Buy Now249.79%EF Hutton
Tony Butler
 → $17ReiteratesBuy → BuyGet Alert
06/20/2023Buy Now249.79%EF Hutton
Tony Butler
 → $17Initiates → BuyGet Alert
05/16/2023Buy Now188.07%Oppenheimer
Leland Gershell
 → $14Reiterates → OutperformGet Alert
03/24/2023Buy Now188.07%Oppenheimer
Leland Gershell
 → $14Initiates → OutperformGet Alert

FAQ

Q

What is the target price for CalciMedica (CALC) stock?

A

The latest price target for CalciMedica (NASDAQ:CALC) was reported by Oppenheimer on July 10, 2024. The analyst firm set a price target for $20.00 expecting CALC to rise to within 12 months (a possible 311.52% upside). 11 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CalciMedica (CALC)?

A

The latest analyst rating for CalciMedica (NASDAQ:CALC) was provided by Oppenheimer, and CalciMedica maintained their outperform rating.

Q

When was the last upgrade for CalciMedica (CALC)?

A

There is no last upgrade for CalciMedica

Q

When was the last downgrade for CalciMedica (CALC)?

A

There is no last downgrade for CalciMedica.

Q

When is the next analyst rating going to be posted or updated for CalciMedica (CALC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CalciMedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CalciMedica was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.

Q

Is the Analyst Rating CalciMedica (CALC) correct?

A

While ratings are subjective and will change, the latest CalciMedica (CALC) rating was a maintained with a price target of $14.00 to $20.00. The current price CalciMedica (CALC) is trading at is $4.86, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch